In schedule 24, after paragraph 18 insert—

“18A.

In the case of a medicinal product, other than a radiopharmaceutical, that is required by Article 54a of the 2001 Directive to bear safety features—

(a)

a unique identifier which complies with the technical specifications set out in Chapter II of Commission Regulation 2016/161; and

(b)

an anti-tampering device allowing verification of whether the packaging of the medicinal product has been tampered with.”.